Advertisement

Tissue Engineering and Regenerative Medicine

, Volume 10, Issue 5, pp 260–265 | Cite as

Retinyl retinoate, a retinoid derivative improves acne vulgaris in double-blind, vehicle-controlled clinical study

  • Bora Kim
  • Hyunjung Kim
  • Jin Eun Kim
  • Seung Hun LeeEmail author
Original Article

Abstract

Topical retinoids have been an important therapy used in the treatment of acne. However, retinoids often have adverse effects that range from mild to moderate local irritation. Retinyl retinoate is a member of a new generation of well-tolerated synthetic retinoids used as a topical retinoid treatment. To assess retinyl retinoate 0.05% for acne vulgaris therapy, fifteen female patients with mild to moderate facial acne prevalence were included in a double-blind, placebo-controlled, split-face trial for 8 weeks by investigators and measurement of sebum amount. In addition, retinyl retinoate was measured in anti-bacterial efficacy by an agar plate diffusion assay. Retinyl retinoate showed a significant decrease in both inflammatory and non-inflammatory lesions, and in sebum amount at 8 weeks (P < 0.05). The application of retinyl retinoate is effective and no local side effects for acne lesions. Retinyl retinoate had somewhat anti-bacterial activity against Propionibacterium acnes (P. acnes). These results indicate that retinyl retinoate can be used as treatment for mild acne or could potentiate the efficiency of an additive anti-acne agent. Retinyl retinoate is possible to be suggested as a topical anti-acne treatment with excellent tolerance.

Key words

topical retinoid retinyl retinoate acne vulgaris sebum 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CN Collier, JC Harper, WC Cantrell, et al., The prevalence of acne in adults 20 years and older, J Am Acad Dermatol, 58, 56 (2008).PubMedCrossRefGoogle Scholar
  2. 2.
    B Dréno, Assessing quality of life in patients with acne vulgaris: implications for Treatment, Am J Clin Dermato, 7, 99 (2006).CrossRefGoogle Scholar
  3. 3.
    I Kurokawa, FW Danby, Q Ju, X Wang, et al., New developments in our understanding of acne pathogenesis and treatment, Exp Dermatol, 18, 821 (2009).PubMedCrossRefGoogle Scholar
  4. 4.
    A Thielitz, MB Abdel-Naser, JW Fluhr, et al., Topical retinoids in acne—an evidence-based overview, J Dtsch Dermatol Ges, 6, 1023 (2008).PubMedCrossRefGoogle Scholar
  5. 5.
    D Thiboutot, H Gollnick, V Bettoli, et al., New insights into the management of acne: an update from the global alliance to improve outcomes in acne group, J Am Acad Dermatol, 60, S1 (2009).PubMedCrossRefGoogle Scholar
  6. 6.
    AF Alexis, Clinical considerations on the use of concomitant therapy in the treatment of acne, J Dermatol Treat, 19, 199 (2008).CrossRefGoogle Scholar
  7. 7.
    B Amichai, A Shemer, MH Grunwald, Low-dose isotretinoin in the treatment of acne vulgaris, J Am Acad Dermatol, 54, 644 (2006).PubMedCrossRefGoogle Scholar
  8. 8.
    A Akhavan, S Bershad, Topical acne drugs: review of clinical properties, systemic exposure, and safety, Am J Clin Dermatol 4, 473 (2003).PubMedCrossRefGoogle Scholar
  9. 9.
    JW Fluhr, MP Vienne, C Lauze, et al., Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions, Dermatol, 199, 57 (1999).Google Scholar
  10. 10.
    RL Warner, N Bhagavathula, K Nerusu, et al., MDI 301, a nonirritating retinoid, improves abrasion wound healing in damaged/atrophic skin, Wound Repair Regen, 16, 117 (2008).PubMedCrossRefGoogle Scholar
  11. 11.
    H Kim, B Kim, H Kim, et al., Synthesis and in vitro biological activity of retinyl retinoate, a novel hybrid retinoid derivative, Bioorg Med Chem, 16, 6387 (2008).CrossRefGoogle Scholar
  12. 12.
    H Kim, N Kim, S Jung, et al., Improvement in skin wrinkles from the use of photostable retinyl retinoate: a randomized controlled trial, Br J Dermatol, 162, 497 (2010).PubMedCrossRefGoogle Scholar
  13. 13.
    KJ Sung, YS Rho, EH Choi, et al., Korean acne grading system, Korean J Dermatol, 42, 1241 (2004).Google Scholar
  14. 14.
    HPM Gollnick, A Krautheim, Topical treatment in acne: current status and future aspects, Dermatol, 206, 29 (2003).CrossRefGoogle Scholar
  15. 15.
    JM Waller, F Dreher, S Behnam, et al., Keratolytic properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man, Skin Pharm Physiol, 19, 283 (2006).CrossRefGoogle Scholar
  16. 16.
    CL Goh, MBY Tang, P Briantais, et al., Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins, J Dermatol Treat. 20, 282 (2009).CrossRefGoogle Scholar
  17. 17.
    J Domínguez, MT Hojyo, JL Celayo, et al., Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris, Int J Dermatol, 37, 54 (1998).PubMedCrossRefGoogle Scholar
  18. 18.
    JE Kim, B Kim, H Kim, et al., Retinyl retinoate induces hyaluronan production and less irritation than other retinoids, J Dermatol, 37, 448 (2010).PubMedCrossRefGoogle Scholar
  19. 19.
    SW Youn, The role of facial sebum secretion in acne pathogenesis: facts and controversies, Clin Dermatol, 28, 8 (2010).PubMedCrossRefGoogle Scholar
  20. 20.
    HH Tan, Antibacterial therapy for acne: a guide to selection and use of systemic agents, Am J Clin Dermatol, 4, 307 (2003).PubMedCrossRefGoogle Scholar
  21. 21.
    M Pechère, L Germanier, G Siegenthaler, et al., The antibacterial activity of topical retinoids: the case of retinaldehyde, Dermatol, 205, 153 (2002).CrossRefGoogle Scholar
  22. 22.
    B Kim, JE Kim, H Kim, et al., Co-treatment with retinyl retinoate and a PPARα agonist reduces retinoid dermatitis. Int J Dermatol, 51(6), 733 (2012)PubMedCrossRefGoogle Scholar
  23. 23.
    H Kim, J Koh, J Baek, et al., Retinyl retinoate, a novel hybrid vitamin derivative, improves photoaged skin: a double-blind, randomized-controlled trial, Skin Res Technol, 17, 380 (2011)PubMedCrossRefGoogle Scholar

Copyright information

© The Korean Tissue Engineering and Regenerative Medicine Society and Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Bora Kim
    • 1
  • Hyunjung Kim
    • 2
  • Jin Eun Kim
    • 1
  • Seung Hun Lee
    • 3
    Email author
  1. 1.R&D Center of Skin Science and CosmeticsEnprani Co., Ltd.IncheonSouth Korea
  2. 2.Departments of Dermatology/Atopy and Asthma center & Seoul Medical Research InstituteSeoul Medical CenterSeoulSouth Korea
  3. 3.Department of Dermatology and Human Barrier Research InstituteYonsei University College of MedicineSeoulSouth Korea

Personalised recommendations